» Articles » PMID: 32205324

HIV-1 Spliced RNAs Display Transcription Start Site Bias

Overview
Journal RNA
Specialty Molecular Biology
Date 2020 Mar 25
PMID 32205324
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Human immunodeficiency virus type 1 (HIV-1) transcripts have three fates: to serve as genomic RNAs, unspliced mRNAs, or spliced subgenomic mRNAs. Recent structural studies have shown that sequences near the 5' end of HIV-1 RNA can adopt at least two alternate three-dimensional conformations, and that these structures dictate genome versus unspliced mRNA fates. HIV-1's use of alternate transcription start sites (TSS) can influence which RNA conformer is generated, and this choice, in turn, dictates the fate of the unspliced RNA. The structural context of HIV-1's major 5' splice site differs in these two RNA conformers, suggesting that the conformers may differ in their ability to support HIV-1 splicing events. Here, we tested the hypothesis that TSS that shift the RNA monomer/dimer structural equilibrium away from the splice site sequestering dimer-competent fold would favor splicing. Consistent with this hypothesis, the results showed that the 5' ends of spliced HIV-1 RNAs were enriched in 3G structures and depleted of 1G RNAs relative to the total intracellular RNA population. These findings expand the functional significance of HIV-1 RNA structural dynamics by demonstrating roles for RNA structure in defining all three classes of HIV-1 RNAs, and suggest that HIV-1 TSS choice initiates a cascade of molecular events that dictate the fates of nascent HIV-1 RNAs.

Citing Articles

HIV-1 single transcription start site mutants display complementary replication functions that are restored by reversion.

Gc K, Lesko S, Emery A, Burnett C, Gopal K, Clark S bioRxiv. 2024; .

PMID: 39677600 PMC: 11643096. DOI: 10.1101/2024.12.04.626847.


Role of RNA structural plasticity in modulating HIV-1 genome packaging and translation.

Yasin S, Lesko S, Kharytonchyk S, Brown J, Chaudry I, Geleta S Proc Natl Acad Sci U S A. 2024; 121(33):e2407400121.

PMID: 39110735 PMC: 11331132. DOI: 10.1073/pnas.2407400121.


Causes, functions, and therapeutic possibilities of RNA secondary structure ensembles and alternative states.

Bose R, Saleem I, Mustoe A Cell Chem Biol. 2024; 31(1):17-35.

PMID: 38199037 PMC: 10842484. DOI: 10.1016/j.chembiol.2023.12.010.


Transcription start site heterogeneity and its role in RNA fate determination distinguish HIV-1 from other retroviruses and are mediated by core promoter elements.

Kharytonchyk S, Burnett C, Gc K, Telesnitsky A J Virol. 2023; 97(9):e0081823.

PMID: 37681957 PMC: 10537674. DOI: 10.1128/jvi.00818-23.


Transcription start site heterogeneity and its role in RNA fate determination distinguish HIV-1 from other retroviruses and are mediated by core promoter elements.

Kharytonchyk S, Burnett C, Gc K, Telesnitsky A bioRxiv. 2023; .

PMID: 37292892 PMC: 10245945. DOI: 10.1101/2023.05.22.541776.


References
1.
Ooms M, Verhoef K, Southern E, Huthoff H, Berkhout B . Probing alternative foldings of the HIV-1 leader RNA by antisense oligonucleotide scanning arrays. Nucleic Acids Res. 2004; 32(2):819-27. PMC: 373333. DOI: 10.1093/nar/gkh206. View

2.
Karn J, Stoltzfus C . Transcriptional and posttranscriptional regulation of HIV-1 gene expression. Cold Spring Harb Perspect Med. 2012; 2(2):a006916. PMC: 3281586. DOI: 10.1101/cshperspect.a006916. View

3.
Girard C, Will C, Peng J, Makarov E, Kastner B, Lemm I . Post-transcriptional spliceosomes are retained in nuclear speckles until splicing completion. Nat Commun. 2012; 3:994. DOI: 10.1038/ncomms1998. View

4.
Adachi A, Gendelman H, Koenig S, Folks T, Willey R, Rabson A . Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol. 1986; 59(2):284-91. PMC: 253077. DOI: 10.1128/JVI.59.2.284-291.1986. View

5.
Greatorex J . The retroviral RNA dimer linkage: different structures may reflect different roles. Retrovirology. 2004; 1:22. PMC: 516450. DOI: 10.1186/1742-4690-1-22. View